Data is not available at this time.
Chiyoda Integre Co., Ltd. operates as a specialized manufacturer of structural and functional components, serving diverse industries including office automation, automotive, telecommunications, and home appliances. The company’s product portfolio spans precision parts such as insulation materials, shielding components, and LED lighting solutions, alongside niche offerings like medical-grade antimicrobial agents and surgical sponge processing. Its vertically integrated capabilities—from pressed products to skin sewing—allow for tailored solutions that cater to both industrial and consumer applications. Positioned in Japan’s competitive hardware and equipment sector, Chiyoda Integre differentiates itself through technical expertise in material science and a diversified client base that mitigates sector-specific risks. While its domestic market remains core, international operations contribute to revenue resilience. The firm’s focus on high-margin niche segments, such as medical and LED components, underscores its strategic shift toward value-added manufacturing amid broader industry commoditization pressures.
For FY 2024, Chiyoda Integre reported revenue of ¥41.2 billion, with net income of ¥3.2 billion, reflecting a net margin of approximately 7.8%. Operating cash flow stood at ¥5.2 billion, supported by disciplined cost management, while capital expenditures of ¥1.4 billion indicate moderate reinvestment. The company’s cash conversion efficiency appears robust, with operating cash flow covering capex nearly four times over.
Diluted EPS of ¥310.86 highlights the firm’s earnings stability, bolstered by its diversified product mix. The modest debt-to-equity ratio, inferred from total debt of ¥1.4 billion against cash reserves of ¥18.2 billion, suggests strong capital efficiency and low financial leverage. This positions the company to fund growth initiatives organically while maintaining liquidity buffers.
Chiyoda Integre’s balance sheet remains solid, with ¥18.2 billion in cash and equivalents dwarfing its ¥1.4 billion total debt. This liquidity profile, coupled with negligible leverage, provides ample flexibility for strategic investments or shareholder returns. The absence of significant debt maturities near-term further reduces financial risk.
The company’s growth trajectory is tempered by its mature domestic market, though international segments and niche products like medical components offer incremental opportunities. A dividend of ¥160 per share signals a commitment to returning capital, with a payout ratio of roughly 51% of net income, balancing reinvestment needs with shareholder expectations.
At a market cap of ¥26.3 billion, the stock trades at a P/E of ~8.1x based on FY 2024 earnings, reflecting modest growth expectations. A beta of 0.155 suggests low volatility relative to the broader market, aligning with its stable but slow-growth profile.
Chiyoda Integre’s competitive edge lies in its technical specialization and diversified industrial exposure, which insulate it from cyclical downturns in any single sector. Near-term challenges include cost pressures from raw materials and global supply chain disruptions, but its strong balance sheet and focus on high-margin niches position it for steady, if unspectacular, performance.
Company filings, market data
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |